• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

VU0119498 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759037

VU0119498 is a M1 muscarinic receptor agonist (EC50 = 3.1uM) and pan mAChR M3, M5 positive allosteric modulator (PAM), and is a neuroprotective agent. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
VU0119498, Inhibitor
Full Product Name
VU0119498
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
100.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
316.15
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C15H10BrNO2
SMILES
Brc1ccc(CN2C(=O)C(=O)c3ccccc23)cc1
CAS Number
79183-37-2
Target & IC50
M1 muscarinic receptor: ic50 3.1uM (EC50)
muscarinic receptor, M1: ic50 3.1uM (EC50)
In Vitro
VU0119498 treatment of wild-type mice caused a significant increase in plasma insulin levels, accompanied by a striking improvement in glucose tolerance

Product Categories/Family for VU0119498, inhibitor

Structure of VU0119498, inhibitor

VU0119498 Inhibitor – Cat# MBS5759037

Product References and Citations for VU0119498, inhibitor

Lu Zhu,et al. Allosteric Modulation of beta-Cell M 3 Muscarinic Acetylcholine Receptors Greatly Improves Glucose Homeostasis in Lean and Obese Mice.Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18684-18690.
Lu Zhu, Mario Rossi,et al. Allosteric Modulation of beta-Cell M 3 Muscarinic Acetylcholine Receptors Greatly Improves Glucose Homeostasis in Lean and Obese Mice.Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18684-18690.
Lu Zhu, Mario Rossi,et al. Allosteric Modulation of beta-Cell M 3 Muscarinic Acetylcholine Receptors Greatly Improves Glucose Homeostasis in Lean and Obese Mice.Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18684-18690.
Bridges T M, Kennedy J P, Cho H P, et al. Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M5 PAM[J]. Bioorganic & Medicinal Chemistry Letters, 2010, 20(2):558-562.
Thomas M Bridges,et al.Heterobiaryl and Heterobiaryl Ether Derived M5 Positive Allosteric Modulators. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5617-2
Thomas M Bridges,et al.Heterobiaryl and Heterobiaryl Ether Derived M5 Positive Allosteric Modulators. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5617-22.

Other Notes

Small volumes of VU0119498, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for VU0119498 purchase

MBS5759037 is an inhibitor targeting VU0119498.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000